# A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults

> **NCT05652660** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ARV-471
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT05652660
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-09
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-03-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05652660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05652660, "A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05652660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*